Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class ASZSE: 002603

Shijiazhuang Yiling Pharmaceutical Co: Revenue and profit declined sharply year-over-year, but operating cash flow improved

· Issued by Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

Q3 2024 revenue fell 1.3% year-over-year, with net profit down 84.07%. YTD revenue and profit dropped sharply due to lower demand and reduced government support, but operating cash flow improved significantly.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

All Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A news releases